Skip to main content

Table 1 Clinical data of HCM and DCM patients

From: MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM

  HCM DCM p
Sample number 10 10  
Mean age (years) 39 ± 14 47 ± 14 0.23
Male sex (%) 80% 80% 1
BMI (kg/m2) 22 ± 4.31 20 ± 1.51 0.26
UCG    
 LVEF (%) 30.29 ± 10.42 25 ± 6.37 0.21
 LVEDD (mm) 61.6 ± 14.04 68.6 ± 7.98 0.21
 IVS (mm) 13.98 ± 3.16 8.9 ± 1.36 0.001**
 LVPW (mm) 10.48 ± 3.33 8.6 ± 1.28 0.141
Comorbidities
 Hypertension 20% (2) 0 0.151
 Ventricular tachycardia 40% (4) 40% (4) 1
 Diabetes 10% (1) 50% (5) 0.054
 Myocardial infarction 0 0 1
 Atrial fibrillation 40% (4) 50% (5) 0.673
Medications    
 Digoxin 50% (5) 70% (7) 0.388
 β-blocker 80% (8) 40% (4) 0.074
 Aldosterone antagonist 70% (7) 50% (5) 0.388
 ACE inhibitor/ARB 20% (2) 20% (2) 1
Mean heart weight (g) 542.1 ± 144.88 380.9 ± 61.01 0.01*
  1. Data are expressed as mean ± SD
  2. BMI body mass index; UCG ultrasound cardiogram; LVEF left ventricular ejection fraction; LVEDD left ventricular end diastolic diameter; IVS interventricular septum; LVPW left ventricular posterior wall; ARB Angiotension receptor blocker
  3. *p < 0.05, **p < 0.01, ***p < 0.001